Efficacy and Safety of 0.5 mg Ranibizumab Compared with Intravitreal Implant Containing 0.7 mg Dexamethasone in Patients with Central Retinal Vein Occlusion Over 6 Months: The COMRADE-C Study

ISSN
1423-0267
0030-3755
Date Issued
2014
Author(s)
Eter, Nicole
Hattenbach, Lars-Olof
Rehak, Matus
Pankaj, Puri
Berk, Huesnue
Knorr, Thomas